2016-08-11T16:44:29-05:00 2015-09-30 420714325 RSM US LLP 1861 INTERNATIONAL DRIVE SUITE 400 MCLEAN VA 22102 990 2014-10-01 362496678 SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING SOCI 7037089000 1850 SAMUEL MORSE DRIVE RESTON VA 20190 VIRGINIA PAPPAS CEO 7037089000 2016-08-05 1 YONG ZHANG CPA P01249785 7033366400 2014 2016-12-15 16:53:06Z VIRGINIA PAPPAS 1850 SAMUEL MORSE DRIVE RESTON VA 20190 12740939 0 X WWW.SNMMI.ORG X 1954 WA TO IMPROVE HEALTH CARE BY ADVANCING NUCLEAR MEDICINE AND MOLECULAR IMAGING. 14 14 59 457 565970 -188400 1016265 997944 8284086 8504128 780727 154379 746844 830670 10827922 10487121 320300 544602 0 0 4575194 4756275 0 0 267281 5551098 5765634 10446592 11066511 381330 -579390 11400950 10597110 1530311 1593159 9870639 9003951 X THE SOCIETY IS A MULTIDISCIPLINARY PROFESSIONAL MEDICAL ORGANIZATION DEDICATED TO THE ADVANCEMENT OF EXCELLENCE IN THE EDUCATION, RESEARCH, AND CLINICAL PRACTICE OF NUCLEAR MEDICINE. 0 0 2075147 1350 1524746 PUBLICATIONS - JOURNAL OF NUCLEAR MEDICINE AND JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY PROVIDE MEMBERSHIP WITH UP-TO- DATE INFORMATION ON CURRENT DEVELOPMENTS IN THE FIELD. 1828490 180 3795979 MEETINGS - PROVIDE SCIENTIFIC AND CLINICAL EDUCATION IN THE NUCLEAR MEDICINE FIELD. EXHIBITS HELP KEEP MEMBERS ABREAST OF THE LATEST DEVELOPMENTS IN THE FIELD. 1644944 4750 77500 LEADERSHIP - EXPENDITURES RELATED TO THE ORGANIZATION'S GOVERNANCE, STRATEGIC PLANNING AND BOARD-LEVEL OUTREACH TO INDUSTRY AND OTHER PROFESSIONAL SOCIETIES THROUGHOUT THE WORLD. 1546369 1400 356791 PROFESSIONAL - PROVIDES CONTINUING PROFESSIONAL EDUCATION AND OTHER AVENUES ENABLING PRACTITIONERS TO ADVANCE IN THE NUCLEAR MEDICINE AND MOLECULAR IMAGING FIELDS. 688398 157900 6798 SNMMI CLINICAL TRIALS NETWORK (INCLUDES NMCTG, LLC) 248980 356722 8035 GRANTS AWARDS AND RELATED EXPENSES 175531 0 0 OUTREACH- RAISE AWARENESS AND UNDERSTANDING OF NUCLEAR MEDICINE, MOLECULAR IMAGING AND RADIONUCLIDE THERAPY AMONG PATIENTS AND THE MEDICAL COMMUNITY 161818 0 0 EVIDENCE AND QUALITY - DEVELOP CLINICAL GUIDELINES, PROCEDURE STANDARDS AND APPROPRIATE USE CRITERIA, DEVELOP AND MAINTAIN EVIDENCE- BASED MEASURES FOR STANDARDS IN QUALITY, PERFORMANCE, AND SAFETY IN THE FIELD OF NUCLEAR MEDICINE 66239 15050 62085 COUNCILS 41306 1500 18360 PET CENTER FOR EXCELLENCE 32042 0 214876 HEALTH POLICY AND REGULATORY AFFAIRS 17786 5750 9375 CENTER FOR MOLECULAR IMAGING INNOVATION & TRANSLATION- EFFORTS TO POSITION MOLECULAR IMAGING AND THERAPY AS AN ESSENTIAL TOOL IN PROVIDING THE HIGHEST STANDARDS OF PATIENT CARE AROUND THE WORLD. 0 0 2555505 OTHER PROGRAMS 2978469 538322 3231825 8527050 1 1 0 1 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 1 1 1 0 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 123 0 1 59 1 1 1 1 CA 0 0 0 0 0 0 0 0 X 14 14 0 0 0 0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 0 VA X X VINCENT A PISTILLI CFO 7037089000 1850 SAMUEL MORSE DR RESTON VA 20190 HOSSEIN JADVAR MD PHD MPH PRESIDENT 2.00 X X 0 0 0 SALLY W SCHWARZ MS RPH BCNP PRESIDENT-ELECT 2.00 X X 0 0 0 BENNETT S GREENSPAN MD FACNM VICE PRESIDENT-ELECT 2.00 X X 0 0 0 MICHAEL L MIDDLETON MD FACNM SECRETARY/TREASURER 2.00 X X 0 0 0 PETER HERSCOVITCH MD FACP IMMEDIATE PAST PRESIDENT 2.00 X 0 0 0 AARON T SCOTT CNMT NMAA PRESIDENT OF TECHNOLOGIST SECTION 2.00 X 0 0 0 LEONIE L GORDON MD FACNM SPEAKER OF HOUSE OF DELEGATES 2.00 X 0 0 0 JON A BALDWIN DO DIRECTOR-AT-LARGE 2.00 X 0 0 0 VASKEN DILSIZIAN MD DIRECTOR-AT-LARGE 2.00 X 0 0 0 SARA G JOHNSON MBA CNMT NCT DIRECTOR-AT-LARGE 2.00 X 0 0 0 CINDI LUCKETT-GILBERTMHACNMT DIRECTOR-AT-LARGE 2.00 X 0 0 0 HELEN R NADEL MD DIRECTOR-AT-LARGE 2.00 X 0 0 0 NEIL A PETRY MS RPH BCNP DIRECTOR-AT-LARGE 2.00 X 0 0 0 ANTHONY J SICIGNANO BS CNMT DIRECTOR-AT-LARGE 2.00 X 0 0 0 VIRGINIA PAPPAS CAE CEO (EX-OFFICIO MEMBER) 35.00 X 265236 0 39292 VINCENT A PISTILLI CPA CFO 35.00 X 182458 0 34327 SUSAN BUNNING DIRECTOR OF HPRA 35.00 X 141737 0 29668 ANN LANTHAM GELILLO DIRECTOR OF EDUCATION 35.00 X 155001 0 3699 MATTHEW DICKENS DIRECTOR OF IT 35.00 X 135315 0 12628 REBECCA MAXEY DIRECTOR OF COMMUNICATIONS 35.00 X 135579 0 5997 VICTORIA WENZEL-LAMB DIRECTOR OF LEADERSHIP 35.00 X 113751 0 14121 1129077 0 139732 7 0 1 0 0 250850 747094 997944 TRADE SHOW/CONFERENCE 900099 3810492 2283217 1527275 MEMBERSHIP DUES 900099 2604005 2604005 PUBLICATIONS 541800 1536275 1045105 491170 MEETINGS SPONSORSHIPS 900099 260980 260980 292376 214876 77500 8504128 258290 258290 251281 251281 2108761 2212672 -103911 -103911 -103911 167068 41146 125922 125922 OTHER INCOME 900099 378667 378667 WEB BANNER ADS 900004 74800 74800 453467 10487121 6273125 565970 2650082 378672 378672 100130 100130 65800 65800 521312 390561 105342 25409 3570487 2665428 791624 113435 83064 60702 22312 50 279366 199571 70687 9108 302046 225602 66385 10059 26833 25561 306 966 24000 24000 22864 22864 988324 818340 159590 10394 26961 26961 310193 180031 127299 2863 224131 3900 220231 5264 5264 784401 743896 13396 27109 623004 600822 6760 15422 283768 32106 251662 82148 35486 46662 EQUIPMENT RENTAL/MAINT 622967 545013 77041 913 PRINTING AND PUBS 450031 432152 11613 6266 HONORARIA 244101 244101 0 0 TEMPORARY HELP 152681 115895 17758 19028 893963 631056 236648 26259 11066511 8527050 2272180 267281 200 450 2449456 1036623 56250 354119 702950 41618 76450 269738 300590 6536668 3511680 2755408 3024988 5519411 5382809 11000 16000 11400950 10597110 706645 776760 650672 637746 172994 178653 1530311 1593159 X 8879042 8341174 991597 662777 9870639 9003951 11400950 10597110 -579390 -287298 0 X X 0 1 X 1 0 X 1028834 793098 1122425 1016265 997944 4958566 8591684 9013703 8552515 8030439 8180026 42368367 9620518 9806801 9674940 9046704 9177970 47326933 0 0 0 47326933 206932 329920 432725 396402 509571 1875550 206932 329920 432725 396402 509571 1875550 235410 218055 201717 241725 378667 1275574 10062860 10354776 10309382 9684831 10066208 50478057 0.93760 0.95110 0.03720 0.03030 X SCHEDULE A, PART III, LINE 12, EXPLANATION OF OTHER INCOME: MISCELLANEOUS - 2010 AMOUNT: $ 235,410. 2011 AMOUNT: $ 218,055. 2012 AMOUNT: $ 201,717. 2013 AMOUNT: $ 241,725. 2014 AMOUNT: $ 378,667. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 367418 367418 10740239 11107657 705383 176346 0 0 662269 666919 672594 705383 2707165 4060748 150801 368380 319226 367418 1205825 165567 166730 168149 176346 676792 1015188 402264 402264 3031057 1420762 1610295 1683089 1091624 591465 1420258 999294 420964 3024988 DUE TO AFFILIATES 178653 178653 X 10240969 -287298 41146 -246152 10487121 0 10487121 11107657 41146 41146 11066511 0 11066511 PART X, LINE 2: THE SOCIETY IS EXEMPT FROM FEDERAL INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. INCOME FROM NONEXEMPT FUNCTIONS IS SUBJECT TO INCOME TAXES TO THE EXTENT THAT THE REVENUE EXCEEDS RELATED COSTS. NO NET INCOME WAS TAXABLE IN FISCAL YEAR 2015; ACCORDINGLY, NO PROVISION HAS BEEN MADE FOR EITHER FEDERAL OR STATE INCOME TAXES IN THE ACCOMPANYING FINANCIAL STATEMENTS. IN ADDITION, THE INTERNAL REVENUE SERVICE HAS DETERMINED THE SOCIETY IS NOT A "PRIVATE FOUNDATION." THE SOCIETY ADOPTED THE ACCOUNTING STANDARD ON ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES, WHICH ADDRESSES THE DETERMINATION OF WHETHER TAX BENEFITS CLAIMED OR EXPECTED TO BE CLAIMED ON A TAX RETURN SHOULD BE RECORDED IN THE FINANCIAL STATEMENTS. UNDER THIS GUIDANCE, THE SOCIETY MAY RECOGNIZE THE TAX BENEFIT FROM AN UNCERTAIN TAX POSITION ONLY IF IT IS MORE LIKELY THAN NOT THAT THE TAX POSITION WILL BE SUSTAINED ON EXAMINATION BY TAXING AUTHORITIES, BASED ON THE TECHNICAL MERITS OF THE POSITION. THE TAX BENEFITS RECOGNIZED IN THE FINANCIAL STATEMENTS FROM SUCH A POSITION ARE MEASURED BASED ON THE LARGEST BENEFIT THAT HAS A GREATER THAN 50% LIKELIHOOD OF BEING REALIZED UPON ULTIMATE SETTLEMENT. THE GUIDANCE ON ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES ALSO ADDRESSES DE-RECOGNITION, CLASSIFICATION, INTEREST AND PENALTIES ON INCOME TAXES, AND ACCOUNTING IN INTERIM PERIODS. MANAGEMENT EVALUATED THE SOCIETY'S TAX POSITIONS AND CONCLUDED THAT THE SOCIETY HAD TAKEN NO UNCERTAIN TAX POSITIONS THAT REQUIRE ADJUSTMENT TO THE FINANCIAL STATEMENTS TO COMPLY WITH THE PROVISIONS OF THIS GUIDANCE. GENERALLY, THE SOCIETY IS NO LONGER SUBJECT TO INCOME TAX EXAMINATIONS BY THE U.S. FEDERAL, STATE OR LOCAL TAX AUTHORITIES FOR YEARS BEFORE 2012. PART XI, LINE 2D - OTHER ADJUSTMENTS: COST OF GOODS SOLD ON PART VIII LINE 10B 41,146. PART XII, LINE 2D - OTHER ADJUSTMENTS: COST OF GOODS SOLD ON PART VIII LINE 10B 41,146. 1 EUROPE 0 0 AWARDS AND GRANTS 51050 EAST ASIA AND THE PACIFIC 0 0 AWARDS AND GRANTS 7225 NORTH AMERICA 0 0 AWARDS AND GRANTS 4525 MIDDLE EAST AND NORTH AFRICA 0 0 AWARDS AND GRANTS 750 RUSSIA AND THE NEWLY INDEPENDENT STATES 0 0 AWARDS AND GRANTS 750 SOUTH ASIA 0 0 AWARDS AND GRANTS 750 SUB-SAHARAN AFRICA 0 0 AWARDS AND GRANTS 750 0 0 0 0 0 0 65800 0 65800 EUROPE 2015 POST-DOCTORAL MOLECULAR IMAGING SCHOLAR PROGRAM GRANT 32500 CHECK/WIRE 0 1 0 GRANTS AND AWARDS EUROPE 35 16550 CHECK/WIRE 0 GRANTS AND AWARDS NORTH AMERICA 5 4525 CHECK/WIRE 0 GRANTS AND AWARDS EAST ASIA 11 4225 0 GRANTS AND AWARDS MIDDLE EAST AND NORTH AFRICA 1 750 CHECK/WIRE 0 GRANTS AND AWARDS RUSSIA AND NEWLY INDEPENDENT STATES 1 750 CHECK/WIRE 0 GRANTS AND AWARDS SOUTH ASIA 1 750 CHECK/WIRE 0 GRANTS AND AWARDS SUB-SAHARAN AFRICA 1 750 CHECK/WIRE 0 0 0 0 0 0 0 PART I, LINE 2: AWARDS RANGING FROM $750 TO $1,000 ARE GRANTED TO COVER ALL OR A PORTION OF TRAVEL EXPENSES INCURRED BY AN INDIVIDUAL RELATED TO THEIR ATTENDANCE AT EDUCATIONAL MEETINGS OR CONFERENCES HELD IN THE UNITED STATES. IF THE INDIVIDUAL IS UNABLE TO ATTEND THE MEETING OR CONFERENCE, THE INDIVIDUAL MAY BE DISQUALIFIED FROM RECEIVING FUTURE AWARDS. OTHER AWARDS RANGING FROM $100 TO $8,000 ARE GRANTED AS RECOGNITION OF INDIVIDUAL ACHIEVEMENT WITHIN THE NUCLEAR MEDICINE OR MOLECULAR IMAGING FIELD. PART I, LINE 3: THE ORGANIZATION USES GAAP TO REPORT EXPENDITURES IN A FOREIGN REGION. 1 VANDERBILT MEDICAL CENTER RADIOLOGY CCC-1108 MCN 21ST AVENUE SOUTH NASHVILLE TN 37232 352528741 501(C)(3) 150000 2015 OUTSTANDING PERFORMANCE IN RADIOPHARMACEUTICAL DEVELOPMENT GRANT JOHNS HOPKINS UNIVERSITY 316 GARLAND HALL 3400 N CHARKS STREET BALTIMORE MD 21218 520595110 501(C)(3) 52500 2015-2016 MOLECULAR IMAGING RESEARCH FOR JUNIOR ACADEMIC FACULTY GRANT YALE UNIV GRANTS & CONTRACTS FINANCIAL ADMINISTRATION PO BOX 1873 NEW HAVEN CT 06508 060646973 501(C)(3) 45000 2013-2014 MOLECULAR IMAGING RESEARCH FOR JUNIOR ACADEMIC FACULTY GRANT EMORY UNIVERSITY 1364 CLIFTON ROAD NE ATLANTA GA 30322 580566256 501(C)(3) 37500 2016 NUCLEAR MEDICINE PHYSICS RESIDENCY GRANT UNIVERSITY HOSPITALS CASE MEDICAL CENTER 11100 EUCLID AVENUE MCCO-5062 CLEVELAND OH 44106 900059117 501(C)(3) 37500 2014-2015 NUCLEAR MEDICINE PHYSICS RESIDENCY PROGRAM GRANT REGENTS OF THE UNIVERSITY OF CALIFORNIA 1855 FOLSOM STREET SUITE 425 BOX 8 SAN FRANSISCO CA 94143 946036493 501(C)(3) 20000 2015-2016 MITZI AND WILLIAM BLAHD MD PILOT RESEARCH GRANT UNIV OF CALF REGENTS DAVIS DEPT OF BIOMEDICAL ENGINEERING ONE SHIELDS AVENUE DAVIS CA 95616 946036494 501(C)(3) 17500 2014-2015 PRE-DOCTORAL MOLECULAR IMAGING SCHOLAR PROGRAM GRANT 7 0 SCHOLARSHIP AND TRAVEL AWARDS 105 100130 0 PART I, LINE 2: GRANT RECIPIENTS ARE USUALLY REQUIRED TO PROVIDE DOCUMENTATION SUPPORTING THE USE OF AWARDED FUNDS. IF REQUIRED DOCUMENTATION IS NOT PROVIDED, RECEIPT OF FUTURE AWARDS IS JEOPARDIZED. X X X 0 0 0 0 0 0 0 0 0 VIRGINIA PAPPAS CAE CEO (EX-OFFICIO MEMBER) 264048 0 0 0 1188 0 8925 0 30367 0 304528 0 0 0 VINCENT A PISTILLI CPA CFO 182044 0 0 0 414 0 6844 0 27483 0 216785 0 0 0 SUSAN BUNNING DIRECTOR OF HPRA 141323 0 0 0 414 0 5410 0 24258 0 171405 0 0 0 ANN LANTHAM GELILLO DIRECTOR OF EDUCATION 139185 0 15402 0 414 0 0 0 3699 0 158700 0 0 0 FORM 990, PART VI, SECTION A, LINE 6 PURSUANT TO THE BYLAWS OF THE ORGANIZATION, MEMBERSHIP CLASSIFICATIONS AND RIGHTS ARE AS FOLLOWS: A. FULL MEMBERSHIP: PHYSICIANS, SCIENTISTS OR PHARMACISTS POSSESSING AN ADVANCED DEGREE WHO HAVE PRESENTED CREDENTIALS INDICATING THEIR PROFESSIONAL ACTIVITY, EITHER, MEDICAL, PARAMEDICAL, INVESTIGATIONAL OR EDUCATIONAL IN THE SCIENTIFIC OR CLINICAL DISCIPLINES OF MOLECULAR IMAGING OR NUCLEAR MEDICINE, MAY JOIN THE SOCIETY AS FULL MEMBERS. THIS INCLUDES THE DIAGNOSTIC, THERAPEUTIC OR INVESTIGATIONAL USE OF RADIONUCLIDES OR OTHER MOLECULAR IMAGING TECHNOLOGIES. THESE INDIVIDUALS HAVE THE RIGHT TO VOTE AND TO BE ELECTED AN OFFICER OF THE SOCIETY. THE BOARD OF DIRECTORS BY MAJORITY VOTE MAY EXTEND FULL MEMBERSHIP TO INDIVIDUALS WHO HAVE MADE EXCEPTIONAL CONTRIBUTIONS TO MOLECULAR IMAGING OR NUCLEAR MEDICINE, BUT WHO DO NOT OTHERWISE QUALIFY FOR FULL MEMBERSHIP. B. ASSOCIATE MEMBERSHIP: 1. SCIENTISTS, OR OTHER HEALTH PROFESSIONALS WITH A MASTER OR BACCALAUREATE DEGREE (OR THE EQUIVALENT QUALIFICATION AS DETERMINED BY THE COMMITTEE ON MEMBERSHIP) WHO HAVE PRESENTED CREDENTIALS INDICATING THEIR PROFESSIONAL ACTIVITY, EITHER PARAMEDICAL, INVESTIGATIONAL, OR EDUCATIONAL, IN THE SCIENTIFIC OR CLINICAL DISCIPLINES OF MOLECULAR IMAGING OR NUCLEAR MEDICINE MAY JOIN AS ASSOCIATE MEMBERS. THIS INCLUDES THE DIAGNOSTIC, THERAPEUTIC OR INVESTIGATIONAL USE OF RADIONUCLIDES OR OTHER MOLECULAR IMAGING TECHNOLOGIES. THESE INDIVIDUALS HAVE THE RIGHT TO VOTE BUT MAY NOT BE ELECTED AN OFFICER OF THE SOCIETY. 2. NUCLEAR MEDICINE AND MOLECULAR IMAGING TECHNOLOGISTS, WITH A MASTER OR BACCALAUREATE DEGREE (OR THE EQUIVALENT QUALIFICATION AS DETERMINED BY THE COMMITTEE ON MEMBERSHIP) WHO HAVE PRESENTED CREDENTIALS INDICATING THEIR PROFESSIONAL ACTIVITY, EITHER PARAMEDICAL, INVESTIGATIONAL, OR EDUCATIONAL, IN THE SCIENTIFIC OR CLINICAL DISCIPLINES OF MOLECULAR IMAGING OR NUCLEAR MEDICINE MAY JOIN AS ASSOCIATE MEMBERS. THIS INCLUDES THE DIAGNOSTIC, THERAPEUTIC OR INVESTIGATIONAL USE OF RADIONUCLIDES OR OTHER MOLECULAR IMAGING TECHNOLOGIES. THESE INDIVIDUALS HAVE THE RIGHT TO VOTE BUT MAY NOT BE ELECTED AN OFFICER OF THE SOCIETY. 3. SCIENTIFIC LABORATORY PROFESSIONALS ARE INDIVIDUALS INVOLVED IN MOLECULAR IMAGING RESEARCH AT THE PRE-CLINICAL OR TRANSLATIONAL LEVEL. THESE FIELDS INCLUDE UTILIZATION OF OPTICAL IMAGING, RADIOPHARMACEUTICALS, MRI, MR SPECTROSCOPY, ULTRASOUND, STEM CELL RESEARCH AND CELL TRAFFICKING. MEMBERS MUST HAVE A MASTER OR BACCALAUREATE DEGREE (OR THE EQUIVALENT QUALIFICATION AS DETERMINED BY THE COMMITTEE ON MEMBERSHIP) AND PROVIDE VALID CREDENTIALS INDICATING THEIR TRAINING AND INVOLVEMENT IN ONE OF THESE AREAS OF RESEARCH. THESE INDIVIDUALS WILL HAVE THE RIGHT TO VOTE BUT MAY NOT BE ELECTED AN OFFICER OF THE SOCIETY. C. TECHNOLOGIST MEMBERSHIP: TECHNOLOGISTS WHO HAVE PRESENTED CREDENTIALS INDICATING PROFESSIONAL ACTIVITY IN MOLECULAR IMAGING OR NUCLEAR MEDICINE TECHNOLOGY OR OTHER RELATED FIELDS MAY JOIN THE SOCIETY AS TECHNOLOGIST MEMBERS WITHOUT THE RIGHTS TO VOTE OR TO BE ELECTED AN OFFICER OF THE SOCIETY. THIS MEMBERSHIP DOES INCLUDE MEMBERSHIP IN THE TECHNOLOGIST SECTION WITH THE RIGHT TO VOTE AND TO BE ELECTED AN OFFICER IN THE TECHNOLOGIST SECTION. D. SCIENTIFIC LABORATORY PROFESSIONALS: INDIVIDUALS WHO ARE INVOLVED IN MOLECULAR IMAGING RESEARCH AT THE PRE-CLINICAL OR TRANSLATIONAL LEVEL. THESE FIELDS INCLUDE UTILIZATION OF OPTICAL IMAGING, RADIOPHARMACEUTICALS, MRI, MR SPECTROSCOPY, ULTRASOUND, STEM CELL RESEARCH AND CELL TRAFFICKING. MEMBERS MUST PROVIDE VALID CREDENTIALS INDICATING THEIR TRAINING AND INVOLVEMENT IN ONE OF THESE AREAS OF RESEARCH. THESE INDIVIDUALS MAY JOIN THE SOCIETY WITHOUT THE RIGHTS TO VOTE OR TO BE ELECTED AN OFFICER OF THE SOCIETY. THIS MEMBERSHIP DOES INCLUDE MEMBERSHIP IN THE TECHNOLOGIST SECTION WITH THE RIGHT TO VOTE AND TO BE ELECTED AN OFFICER IN THE TECHNOLOGIST SECTION. E. MEMBERS-IN-TRAINING (STUDENT, RESIDENT, FELLOW): PHYSICIANS, SCIENTISTS, AND TECHNOLOGISTS WHO ARE ENROLLED IN ACCREDITED TRAINING PROGRAMS OR POSTDOCTORAL FELLOWSHIPS MAY JOIN THE SOCIETY AS MEMBERS-IN-TRAINING WITH ALL RIGHTS AND PRIVILEGES OF MEMBERSHIP, EXCEPT THE RIGHTS TO VOTE AND TO BE ELECTED AN OFFICER OF THE SOCIETY. F. AFFILIATE MEMBERSHIP: INDIVIDUALS COMMITTED TO THE ADVANCEMENT OF NUCLEAR MEDICINE, BUT NOT QUALIFYING FOR MEMBERSHIP IN OTHER CATEGORIES, MAY JOIN THE SOCIETY AS AFFILIATE MEMBERS WITH ALL RIGHTS AND PRIVILEGES OF MEMBERSHIP, EXCEPT THE RIGHTS TO VOTE AND TO BE ELECTED AN OFFICER OF THE SOCIETY. G. HONORARY MEMBERSHIP: INDIVIDUALS WHO HAVE RENDERED OUTSTANDING SERVICE IN AN AREA OF NUCLEAR MEDICINE MAY BE GRANTED HONORARY MEMBERSHIP IN THE SOCIETY WITH ALL RIGHTS AND PRIVILEGES OF MEMBERSHIP, EXCEPT THE RIGHTS TO VOTE AND TO BE ELECTED AN OFFICER OF THE SOCIETY. H. EMERITUS MEMBERSHIP: INDIVIDUALS UPON THEIR RETIREMENT AFTER AT LEAST TEN (10) YEARS OF CONSECUTIVE MEMBERSHIP IN THE SOCIETY MAY BE GRANTED EMERITUS MEMBERSHIP. EMERITUS MEMBERS HAVE THE FULL PRIVILEGES OF THE MEMBERSHIP CATEGORY FROM WHICH THEY ENTERED THE EMERITUS STATUS EXCEPT THE RIGHT TO BE ELECTED AN OFFICER OF THE SOCIETY. FORM 990, PART VI, SECTION A, LINE 7A SEE EXPLANATION FOR FORM 990, PART VI, SECTION A, LINE 6. FORM 990, PART VI, SECTION A, LINE 7B PURSUANT TO THE BYLAWS OF THE ORGANIZATION, THE HOUSE OF DELEGATES HAS CERTAIN RIGHTS AS FOLLOWS 1. DESCRIPTION: THE HOUSE OF DELEGATES IS THE REPRESENTATIVE COMPONENT OF THE SOCIETY. 2. RESPONSIBILITIES: A. TO DEVELOP AND RECOMMEND TO THE BOARD OF DIRECTORS, SOCIETY POLICIES AND PROGRAMS REGARDING PROFESSIONAL ISSUES AFFECTING NUCLEAR MEDICINE. B. TO PROVIDE THE SEVEN (7) DIRECTORS-AT-LARGE, THE MAJORITY OF THE VOTING MEMBERS OF THE BOARD OF DIRECTORS. C. TO APPROVE AMENDMENTS TO THE BYLAWS IN ACCORD WITH THE BYLAWS AND PROCEDURES. D. TO APPROVE ESTABLISHMENT, SUSPENSION, AND DISSOLUTION OF CHAPTERS AND COUNCILS. E. TO REVIEW THE STRATEGIC PLAN ANNUALLY. F. TO OVERSEE AND MONITOR THE WORK OF THE COMMITTEES OF THE HOUSE OF DELEGATES. G. TO ELECT THE SPEAKER OF THE HOUSE, THE VICE SPEAKER OF THE HOUSE, AND THE HISTORIAN. H. TO ELECT THE MEMBERS-AT-LARGE OF THE COMMITTEE ON NOMINATIONS. I. TO APPROVE THE SELECTION OF THE EDITOR OF THE JOURNAL OF NUCLEAR MEDICINE. 3. COMPOSITION, SELECTION, AND TERM: A. THE HOUSE OF DELEGATES SHALL BE COMPOSED OF VOTING AND NONVOTING MEMBERS: 1. VOTING MEMBERS A) CHAPTER DELEGATES: TWO (2) DELEGATES FROM EACH GEOGRAPHICAL CHAPTER REGION B) COUNCIL DELEGATES: TWO (2) DELEGATES FROM EACH COUNCIL C) CENTER DELEGATES: TWO (2) DELEGATES FROM EACH CENTER D) TECHNOLOGIST SECTION DELEGATES: EIGHT (8) DELEGATES E) THE HISTORIAN OF THE SOCIETY. 2. NON-VOTING MEMBERS: A) THE OFFICERS OF THE SOCIETY AND THE TECHNOLOGIST SECTION PRESIDENT B) THE LAST FIVE (5) PAST PRESIDENTS OF THE SOCIETY. B. SELECTION OF VOTING MEMBERS: 1. DELEGATES FROM CHAPTERS, COUNCILS, CENTERS, AND THE TECHNOLOGIST SECTION MAY BE SELECTED BY VARIOUS METHODS DEVISED BY EACH OF THOSE BODIES. 2. THE HISTORIAN SHALL BE ELECTED BY THE HOUSE OF DELEGATES AND IS AN OFFICER OF THE HOUSE OF DELEGATES. C. TERM: 1. DELEGATES FROM CHAPTERS, COUNCILS, CENTERS, AND THE TECHNOLOGIST SECTION MAY SERVE FOR SUCH TERMS AS THOSE BODIES MAY PROVIDE, BUT A DELEGATE MAY SERVE FOR A MAXIMUM OF SIX (6) CONSECUTIVE YEARS; FOLLOWING SERVICE AS A VOTING DELEGATE, AT LEAST THREE (3) YEARS MUST ELAPSE BEFORE SERVICE AS A VOTING DELEGATE IS AGAIN PERMITTED. HOWEVER, A DELEGATE ELECTED AS A DIRECTOR-AT-LARGE SHALL REMAIN A VOTING DELEGATE FOR THE DURATION OF THE TERM AS DIRECTOR-AT-LARGE, EVEN IF BY DOING SO THE DELEGATE EXCEEDS EITHER THE TERM AS DELEGATE OR TERM LIMIT. ANY THREE (3)-YEAR ABSENCE AS A VOTING DELEGATE IN THE HOUSE MAY BE FOLLOWED BY SERVICE AS A VOTING DELEGATE FOR UP TO SIX (6) YEARS. 2. THE HISTORIAN SHALL SERVE A THREE (3)-YEAR TERM AND MAY BE ELECTED TO ONE CONSECUTIVE TERM. THE HISTORIAN CAN EXCEED THE SIX (6)-YEAR TERM LIMIT TO COMPLETE THE TERM AS HISTORIAN. 4. MEETINGS: A. REGULAR AND ANNUAL MEETINGS: 1. THE HOUSE OF DELEGATES SHALL HAVE AT LEAST TWO REGULAR MEETINGS EACH YEAR. ONE OF THE REGULAR MEETINGS SHALL BE DESIGNATED AS THE ANNUAL MEETING AND SHALL BE HELD IN CONJUNCTION WITH THE ANNUAL MEETING OF THE SOCIETY. 2. FORMAL NOTICE OF REGULAR AND ANNUAL MEETINGS OF THE HOUSE OF DELEGATES SHALL BE PUBLISHED. B. SPECIAL MEETINGS: SPECIAL MEETINGS OF THE HOUSE OF DELEGATES SHALL BE SUMMONED BY THE BOARD OF DIRECTORS OR THE SPEAKER OF THE HOUSE, AS CIRCUMSTANCES WARRANT. C. NOTIFICATION: DELEGATES SHALL BE GIVEN AT LEAST SIXTY (60) DAYS ADVANCE NOTICE OF THE TWO REGULARLY SCHEDULED MEETINGS OF THE HOUSE OF DELEGATES AND FIVE (5) WORKING-DAYS NOTICE OF A SPECIAL MEETING OF THE HOUSE OF DELEGATES. D. QUORUM: A QUORUM FOR ALL MEETINGS OF THE HOUSE OF DELEGATES IS A MAJORITY OF THE TOTAL VOTING DELEGATES. 5. REMOVAL OF THE ORGANIZATION'S MEMBERS FROM OFFICE: ELECTED MEMBERS: INDIVIDUALS HOLDING AN ELECTED OFFICE UNDER THESE BYLAWS MAY BE REMOVED FROM OFFICE BY A TWO-THIRDS (2/3) AFFIRMATIVE VOTE OF THE HOUSE OF DELEGATES. A. FORMAL CHARGES WILL BE CIRCULATED TO ALL MEMBERS OF THE HOUSE OF DELEGATES AND TO THE INDIVIDUAL CHARGED AT LEAST THIRTY (30) DAYS PRIOR TO THE MEETING OF THE HOUSE OF DELEGATES AT WHICH THE ISSUE WILL BE ADDRESSED. B. THE INDIVIDUAL CHARGED WILL HAVE THE RIGHT TO PERSONAL APPEARANCE AND DEFENSE AT A REGULAR OR SPECIAL MEETING OF THE HOUSE OF DELEGATES AT WHICH THE ISSUE WILL BE ADDRESSED. APPOINTED MEMBERS: COMMITTEE MEMBERS OR ANY OTHER APPOINTED INDIVIDUAL MAY BE REMOVED FROM OFFICE BY THE APPOINTING AUTHORITY WITH APPROVAL OF A MAJORITY OF THE HOUSE OF DELEGATES AFTER DUE PROCESS PROCEDURES HAVE BEEN COMPLETED. FORM 990, PART VI, SECTION B, LINE 11 A DRAFT OF THE FORM 990 IS REVIEWED BY THE ORGANIZATION'S CFO, CEO AND TREASURER PRIOR TO ITS FILING WITH THE INTERNAL REVENUE SERVICE (IRS). ADDITIONALLY, A COPY OF THE COMPLETED FORM 990 IS TO BE SENT TO EVERY MEMBER OF THE ORGANIZATION'S BOARD OF DIRECTORS PRIOR TO ITS FILING WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C THE ORGANIZATION'S VOTING MEMBERS OF THE HOUSE OF DELEGATES, ALL BOARD MEMBERS, ALL COUNCIL PRESIDENTS, ALL COMMITTEE/COMMISSION CHAIRS, ALL NOMINEES FOR NATIONAL OFFICES, THE EXECUTIVE BOARD OF THE TECHNOLOGIST SECTION, ALL VOTING MEMBERS OF THE TECHNOLOGIST SECTION NATIONAL COUNCIL OF REPRESENTATIVES (COLLECTIVELY REFERRED TO AS "SNMMI LEADERSHIP"), AND KEY EMPLOYEES OF THE ORGANIZATION ARE ALL SUBJECT TO A CONFLICT OF INTEREST POLICY (COI). ANNUALLY, THE BOARD OF DIRECTORS, HOUSE OF DELEGATES, EXECUTIVE BOARD OF THE TECHNOLOGIST SECTION SHALL REVIEW THE DISCLOSURE FORMS OF THEIR MEMBERS OF THE SNMMI LEADERSHIP FOR ANY FINANCIAL OR NON-FINANCIAL INTERESTS OR OTHER SIGNIFICANT CONFLICTS OF INTEREST. MEMBERS WILL DISCLOSE ANY POTENTIAL CONFLICT OF INTEREST BEFORE DISCUSSING THE SUBJECT WHICH INVOLVES A POSSIBLE CONFLICT OF INTEREST AND WILL NOT PARTICIPATE IN ANY ACTION ON THAT SUBJECT UNLESS OFFICIALLY REQUESTED TO DO SO BY THE BODY WHICH IS TAKING THE ACTION. FORM 990, PART VI, SECTION B, LINE 15 THE PROCESS FOR DETERMINING COMPENSATION FOR THE ORGANIZATION'S CEO INCLUDES AN ANNUAL REVIEW OF JOB PERFORMANCE BY THE EXECUTIVE COMMITTEE OR ITS DESIGNEE. ADDITIONALLY, A COMPENSATION COMMITTEE REVIEWS THE CEO'S COMPENSATION AND COMPARES SUCH COMPENSATION TO COMPARATIVE SALARY DATA. THE WORK OF THE COMPENSATION COMMITTEE AND ANY OF ITS DECISIONS ARE DOCUMENTED. THERE IS NO COMPENSATION PAID TO ANY BUSINESS WHICH A CORPORATE OFFICER CONTROLS DIRECTLY OR INDIRECTLY. COMPENSATION FOR ANY KEY EMPLOYEES IS SET FORTH BY THE CEO. IF REQUESTED BY THE EXECUTIVE COMMITTEE OR ITS DESIGNEE, COMPARATIVE SALARY DATA FOR ANY KEY EMPLOYEES WOULD BE PROVIDED. ADDITIONALLY, THE COMPENSATION COMMITTEE REVIEWS THE COMPENSATION OF CERTAIN KEY EMPLOYEES AND COMPARES SUCH COMPENSATION TO COMPARATIVE SALARY INFORMATION. FORM 990, PART VI, SECTION C, LINE 19 COPIES OF ALL GOVERNING DOCUMENTS OF THE ORGANIZATION, THE COI POLICY AND AUDITED FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST FOR THE SAME PERIOD OF DISCLSOURE AS SET FOR IN SECTION 6104(D). THE ORGANIZATION'S BYLAWS ARE AVAILABLE TO THE PUBLIC ON THE WEBSITE. FORM 990, PART XII, LINE 2C THE PROCESS FOR OVERSEEING THE AUDIT OF THE FINANCIAL STATEMENTS AND SELECTION OF AN INDEPENDENT ACCOUNTANT THAT AUDITED THE FINANCIAL STATEMENTS HAS BEEN CONSISTENT WITH PRIOR YEARS. THE EDUCATION & RESEARCH FOUNDATION FOR NUCLEAR MEDICINE & MOLECULAR IMAGIN 14301 FNB PARKWAY SUITE 100 OMAHA NE 68154 237048300 GRANTMAKING NE 501(C)(3) LINE 11B, II N/A 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0